Two drugs converged in a pancreatic β cell.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 32051228.
- Also identified by DOI 10.1126/scitranslmed.aba7359.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Combining a DYRK1A inhibitor and GLP-1 receptor agonist boosts human pancreatic β cell proliferation and glucose homeostasis in vivo (Ackeifi <i>et al.</i>, this issue).
Medical subject headings
- Insulin-Secreting Cells